How T Cells Tell the Difference Between Healthy and Diseased Cells
Mechanisms of ligand discrimination by the T cell signaling machinery
This research explores how our immune system's T cells learn to recognize and respond to threats like diseased cells, while ignoring healthy ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11097193 on NIH RePORTER |
What this research studies
Our T cells are like tiny detectives, constantly scanning the body to find and eliminate threats. They need to be very good at telling the difference between healthy cells and those that are diseased, such as cancer cells or infected cells. This project aims to understand the intricate communication system within T cells that allows them to make these critical decisions. By learning how T cells receive and interpret signals, we hope to unlock new ways to guide them to fight human diseases more effectively.
Who could benefit from this research
Good fit: This foundational research is not recruiting patients directly, but it is relevant to anyone with diseases where T cell function is critical, such as cancer or autoimmune disorders.
Not a fit: Patients seeking immediate treatment options may not directly benefit from this basic science research, as it focuses on fundamental biological understanding.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for using T cells as therapies to treat various human diseases, including cancer and autoimmune conditions.
How similar studies have performed: While much is known about how T cells are connected to signaling proteins, the specific coordination of these proteins to produce different cellular responses is still largely unknown, making this a novel area of focus.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Courtney, Adam — University of Michigan at Ann Arbor
- Study coordinator: Courtney, Adam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.